MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Incompatible

Aripiprazole 10mg orodispersible tablets sugar free (Medihealth (Northern) Ltd)

Explore other Aripiprazole formulations Explore other Aripiprazole 10mg orodispersible tablets sugar free suppliers

Stability Notes

Protect from moisture. Orodispersible in nature therefore likely to be hygroscopic.

Provenance

This compatibility recommendation is derived from Abilify 10mg orodispersible tablets (Otsuka Pharmaceuticals (U.K.) Ltd).

Incompatible

Aripiprazole 10mg orodispersible tablets sugar free (Neon Healthcare Ltd)

Explore other Aripiprazole formulations Explore other Aripiprazole 10mg orodispersible tablets sugar free suppliers

Stability Notes

Protect from moisture. Orodispersible in nature therefore likely to be hygroscopic.

Provenance

This compatibility recommendation is derived from Abilify 10mg orodispersible tablets (Otsuka Pharmaceuticals (U.K.) Ltd).

Incompatible

Aripiprazole 10mg orodispersible tablets sugar free (Thornton & Ross Ltd)

Explore other Aripiprazole formulations Explore other Aripiprazole 10mg orodispersible tablets sugar free suppliers

Stability Notes

Protect from moisture. Orodispersible in nature therefore likely to be hygroscopic.

Provenance

This compatibility recommendation is derived from Abilify 10mg orodispersible tablets (Otsuka Pharmaceuticals (U.K.) Ltd).

Incompatible

Aripiprazole 10mg tablets (A A H Pharmaceuticals Ltd)

Explore other Aripiprazole formulations Explore other Aripiprazole 10mg tablets suppliers

Stability Notes

Very moisture sensitive medicine. Manufacturer recommends storing in original container. Original packaging may contain desiccant.

Provenance

This recommendation is based on the products Abilify 10mg tablets (Otsuka Pharmaceuticals (UK) Ltd) and aripiprazole 10mg tablets (Aurobindo Pharma - Milpharm Ltd).

Incompatible

Aripiprazole 10mg tablets (Accord-UK Ltd)

Explore other Aripiprazole formulations Explore other Aripiprazole 10mg tablets suppliers

Stability Notes

Very moisture sensitive medicine. Manufacturer recommends storing in original container. Original packaging may contain desiccant.

Provenance

This recommendation is based on the products Abilify 10mg tablets (Otsuka Pharmaceuticals (UK) Ltd) and aripiprazole 10mg tablets (Aurobindo Pharma - Milpharm Ltd).

Incompatible

Aripiprazole 10mg tablets (Alliance Healthcare (Distribution) Ltd)

Explore other Aripiprazole formulations Explore other Aripiprazole 10mg tablets suppliers

Stability Notes

Very moisture sensitive medicine. Manufacturer recommends storing in original container. Original packaging may contain desiccant.

Provenance

This recommendation is based on the products Abilify 10mg tablets (Otsuka Pharmaceuticals (UK) Ltd) and aripiprazole 10mg tablets (Aurobindo Pharma - Milpharm Ltd).

Incompatible

Aripiprazole 10mg tablets (Amarox Ltd)

Explore other Aripiprazole formulations Explore other Aripiprazole 10mg tablets suppliers

Stability Notes

Very moisture sensitive medicine. Manufacturer recommends storing in original container. Original packaging may contain desiccant.

Provenance

This recommendation is based on the products Abilify 10mg tablets (Otsuka Pharmaceuticals (UK) Ltd) and aripiprazole 10mg tablets (Aurobindo Pharma - Milpharm Ltd).

Incompatible

Aripiprazole 10mg tablets (Aspire Pharma Ltd)

Explore other Aripiprazole formulations Explore other Aripiprazole 10mg tablets suppliers

Stability Notes

Very moisture sensitive medicine. Manufacturer recommends storing in original container. Original packaging may contain desiccant.

Provenance

This recommendation is based on the products Abilify 10mg tablets (Otsuka Pharmaceuticals (UK) Ltd) and aripiprazole 10mg tablets (Aurobindo Pharma - Milpharm Ltd).

Incompatible

Aripiprazole 10mg tablets (Bristol Laboratories Ltd)

Explore other Aripiprazole formulations Explore other Aripiprazole 10mg tablets suppliers

Stability Notes

Very moisture sensitive medicine. Manufacturer recommends storing in original container. Original packaging may contain desiccant.

Provenance

This recommendation is based on the products Abilify 10mg tablets (Otsuka Pharmaceuticals (UK) Ltd) and aripiprazole 10mg tablets (Aurobindo Pharma - Milpharm Ltd).

Incompatible

Aripiprazole 10mg tablets (Crescent Pharma Ltd)

Explore other Aripiprazole formulations Explore other Aripiprazole 10mg tablets suppliers

Stability Notes

Very moisture sensitive medicine. Manufacturer recommends storing in original container. Original packaging may contain desiccant.

Provenance

This recommendation is based on the products Abilify 10mg tablets (Otsuka Pharmaceuticals (UK) Ltd) and aripiprazole 10mg tablets (Aurobindo Pharma - Milpharm Ltd).

Incompatible

Aripiprazole 10mg tablets (HBS Healthcare Ltd)

Explore other Aripiprazole formulations Explore other Aripiprazole 10mg tablets suppliers

Stability Notes

Very moisture sensitive medicine. Manufacturer recommends storing in original container. Original packaging may contain desiccant.

Provenance

This recommendation is based on the products Abilify 10mg tablets (Otsuka Pharmaceuticals (UK) Ltd) and aripiprazole 10mg tablets (Aurobindo Pharma - Milpharm Ltd).

Incompatible

Aripiprazole 10mg tablets (Key Pharmaceuticals Ltd)

Explore other Aripiprazole formulations Explore other Aripiprazole 10mg tablets suppliers

Stability Notes

Very moisture sensitive medicine. Manufacturer recommends storing in original container. Original packaging may contain desiccant.

Provenance

This recommendation is based on the products Abilify 10mg tablets (Otsuka Pharmaceuticals (UK) Ltd) and aripiprazole 10mg tablets (Aurobindo Pharma - Milpharm Ltd).

Incompatible

Aripiprazole 10mg tablets (Krka UK Ltd)

Explore other Aripiprazole formulations Explore other Aripiprazole 10mg tablets suppliers

Stability Notes

Very moisture sensitive medicine. Manufacturer recommends storing in original container. Original packaging may contain desiccant.

Provenance

This recommendation is based on the products Abilify 10mg tablets (Otsuka Pharmaceuticals (UK) Ltd) and aripiprazole 10mg tablets (Aurobindo Pharma - Milpharm Ltd).

Incompatible

Aripiprazole 10mg tablets (Macleods Pharma UK Ltd)

Explore other Aripiprazole formulations Explore other Aripiprazole 10mg tablets suppliers

Stability Notes

Very moisture sensitive medicine. Manufacturer recommends storing in original container. Original packaging may contain desiccant.

Provenance

This recommendation is based on the products Abilify 10mg tablets (Otsuka Pharmaceuticals (UK) Ltd) and aripiprazole 10mg tablets (Aurobindo Pharma - Milpharm Ltd).

Incompatible

Aripiprazole 10mg tablets (Medical Valley Invest AB)

Explore other Aripiprazole formulations Explore other Aripiprazole 10mg tablets suppliers

Stability Notes

Very moisture sensitive medicine. Manufacturer recommends storing in original container. Original packaging may contain desiccant.

Provenance

This recommendation is based on the products Abilify 10mg tablets (Otsuka Pharmaceuticals (UK) Ltd) and aripiprazole 10mg tablets (Aurobindo Pharma - Milpharm Ltd).

Print this list

Compatible

Medicines suitable for use in MCAs, although use is likely to be off-label.  Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or consider up to 8 weeks if the MCA is airtight (sealed).  Consider the risk to the individual from potency loss or dose variability, particularly with unsealed devices.  Monitor for any changes in therapeutic effect or increased adverse effects after MCA initiation.

Use with caution

There are concerns about stability and/or there is a lack of stability data available. These medicines can theoretically be used in MCAs, although use is likely to be off-label.  Mitigation measures may need to be considered.  Keep medicines in MCAs for the shortest time necessary.  Generally, up to 5 weeks maximum unless otherwise specified, or consider up to 8 weeks if the MCA is airtight (sealed). Consider the risk to the individual from potency loss or dose variability, particularly with unsealed devices. Monitor for any changes in therapeutic effect or increased adverse effects after MCA initiation.

Incompatible

Medicines under this category are not suitable for use in MCAs.

No Stability Information

These medicines have not been reviewed by SPS.